Michael B. Atkins
Beth Israel Deaconess Medical Center
2 papers in the Anchorcite directory, published between 2009 and 2012, cited 17,449 times in total.
ORCID profileResearch topics
- T-cell and B-cell Immunology · 1 paper
- Cancer Immunotherapy and Biomarkers · 1 paper
- Immunotherapy and Immune Responses · 1 paper
- Breast Cancer Treatment Studies · 1 paper
- Cutaneous Melanoma Detection and Management · 1 paper
- Melanoma and MAPK Pathways · 1 paper
Frequent co-authors
- Suzanne Louise Topalian · 1 paper
- Frank Stephen Hodi · 1 paper
- Julie Renee Brahmer · 1 paper
- Scott N. Gettinger · 1 paper
- David Carl Smith · 1 paper
- David F. McDermott · 1 paper
- John D. Powderly · 1 paper
- Richard D. Carvajal · 1 paper
Papers
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine · 2012 · 12,793 citations
BACKGROUND: Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance. We assessed the antitumor activity and safety of BMS-936558, an antibody that specifically blocks PD-1. METHODS: We enrolled patients with advanced melanoma,…
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology · 2009 · 4,656 citations
PURPOSE: To revise the staging system for cutaneous melanoma on the basis of data from an expanded American Joint Committee on Cancer (AJCC) Melanoma Staging Database. METHODS: The melanoma staging recommendations were made on the basis of a multivariate analysis…
Metadata from OpenAlex (CC0).